1. Clinical evidence for combination antibiotic susceptibility testing (synergy testing);Aaron;Pediatric Pulmonology,2008
2. Treatment of CF exacerbations based on multiple combination antibiotic susceptibility testing-a randomised, double-blind, controlled clinical trial;Aaron;Pediatric Pulmonology,2005
3. Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial;Aaron;Lancet,2005
4. Meropenem (MEM) compared with ceftazidime (CAZ) in combination with tobramycin (TOB) for treatment of acute pulmonary exacerbations (APE) in patients with cystic fibrosis (CF) infected with Pseudomonas aeruginosa (PA) or Burkholderia cepacia (BC);Blumer;Pediatric Pulmonology,2003
5. The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis;Blumer;Chest,2005